IDEAS home Printed from https://ideas.repec.org/p/ohe/occpap/000216.html
   My bibliography  Save this paper

New Drugs to Tackle Antimicrobial Resistance: EU Policy Options

Author

Listed:
  • Priya Sharma;Adrian Towse

Abstract

Antimicrobial resistance (AMR) to drugs, a natural and unavoidable consequence of treating infectious diseases, is a growing global public health threat. The EU Commission is to develop comprehensive proposals by the end of 2012 for addressing the situation. This Paper is meant to provide input into those policy discussions. The paper reviews AMR’s implications for the burden of disease, the causes of AMR, the current state of the antibiotic development pipeline and the reasons antibiotic R&D has been de-emphasised by biopharmaceutical companies. Four key sets of factors are identified that provide serious disincentives for R&D. The authors develop a model to assess the push, pull and hybrid approaches that may be applied to reinvigorate the development of new products. Since AMR is global in scope and involves many stakeholders, the authors urge a comprehensive approach that reaches across countries and involves a broad range of interests.

Suggested Citation

  • Priya Sharma;Adrian Towse, 2010. "New Drugs to Tackle Antimicrobial Resistance: EU Policy Options," Occasional Paper 000216, Office of Health Economics.
    • Handle: RePEc:ohe:occpap:000216
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/new-drugs-tackle-antimicrobial-resistance-eu-policy-options/attachment-330-occasional-paper-1-new-drugs-to-tackle-antimicrobial-resistance-wp-sept-1-ps-occasional-paper-10-01/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Brogan, David M. & Mossialos, Elias, 2016. "A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility," LSE Research Online Documents on Economics 66237, London School of Economics and Political Science, LSE Library.

    More about this item

    Keywords

    New Drugs to Tackle Antimicrobial Resistance: EU Policy Options;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:occpap:000216. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.